End Stage COPD Treatment Options at the Lung Institute

The Lung Institute offers innovative stem cell treatment for end stage COPD (chronic obstructive pulmonary disease). Our stem cell therapy, which uses a patient’s own stem cells to potentially help reduce inflammation, promote healing and improve quality of life, can be either blood-based or bone marrow-based. The stem cells used in our procedures are harvested from the patient’s body, separated from other cells in the sample, then reintroduced in a concentrated intravenous infusion that delivers the stem cells directly to the bloodstream. Because we recognize that no two patients are the same, our knowledgeable staff can help each individual determine which of our two stem cell treatment options would best suit his or her specific needs.

Our stem cell therapies can be administered during any stage of COPD, though they may be especially beneficial for individuals with end stage chronic obstructive pulmonary disease. People with late stage COPD are often living with a significant reduction in their lung function and quality of life. This can make it particularly challenging to go to work, exercise or complete daily activities around the house, making an effective treatment plan a necessity.

While medications, lifestyle changes and other similar treatments can help alleviate the symptoms of COPD, stem cell therapy is unique in that it has the potential to slow the progression of the disease. Patients who have undergone treatment at the Lung Institute have experienced benefits such as:

  • Less pain and shortness of breath
  • Less inflammation in the lungs
  • A reduced need for supplemental oxygen during daily activities

Our stem cell therapies are provided on an outpatient basis, allowing patients to return to the comfort of their own homes or hotel accommodations shortly after the infusion process is complete. More than 80 percent of our patients report an improvement in their quality of life after treatment.

To find out if stem cell therapy is right for you, call the Lung Institute at (800) 729-3065 to schedule a free consultation. Our team is here to help you find the right options for your end stage COPD treatment and will be happy to answer any questions you might have.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.